Aprea Therapeutics

-$0.06 (-1.41%) As of 4:01 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell APRE and other ETFs, options, and stocks.

About APRE

Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of cancer therapeutics. It involves in the development and commercialization of novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein.

CEO
Christian S. Schade
Employees
—
Headquarters
Boston, Massachusetts
Founded
2002

APRE Key Statistics

Market Cap
101.84M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
3.32M
High Today
$4.38
Low Today
$4.17
Open Price
$4.25
Volume
187.43K
52 Week High
$31.45
52 Week Low
$3.88

APRE Earnings

-$0.78
-$0.52
-$0.26
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 17, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure